States Ban Cough Syrups After 11 Child Deaths
Following the deaths of 11 children in Madhya Pradesh and Rajasthan linked to contaminated cough syrups, state governments have taken swift action. Rajasthan suspended its drug controller and halted distribution of all medicines from Jaipur-based Kaysons Pharma. Tamil Nadu has banned the sale of 'Coldrif' syrup. The Union Health Ministry has also issued an advisory against prescribing cough and cold medications to children under two. Investigations are underway to determine the cause, with diethylene glycol contamination suspected.
Unpacked:
Diethylene glycol is a toxic chemical used in industrial products, not intended for medicinal use. Its accidental inclusion in medicines can cause kidney failure and death, especially in children, as seen in past international cases of mass poisoning.
Yes, India has faced similar incidents before. In 2022, contaminated cough syrups exported from India were linked to child deaths in Gambia, raising concerns about drug safety and manufacturing standards nationally and internationally.
Authorities have suspended implicated officials, halted distribution from the suspected manufacturer, banned specific products, and issued advisories against prescribing cough syrups to young children. Investigations into manufacturing practices and chemical analysis of syrups are ongoing.
The Health Ministry advises against cough and cold medications for children under two. Non-drug measures like keeping the child hydrated, using saline nasal drops, and monitoring for serious symptoms are recommended. Parents should consult pediatricians for safe care.